https://doi.org/10.4081/hmr.v1i8.275

Treatment of aggressive lymphoma

Vol. 1 No. 8: New Drugs in Hematology, Bologna, October 9-11, 2005
Published: May 29, 2009
Abstract Views: 126
PDF: 159
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Christer Gisselbrecht
support@pagepress.org
Treatment of aggressive B cell lymphomas is rapidly evolving with the introduction of monoclonal antibodies in association with chemotherapy. Reappraisal of the progress made with chemotherapy is important to decide which part of the past strategies with intensive treatment should still be used. Long term results of the first studies with R-CHOP, identify patients more likely to respond to treatment with Bcl2 over expression and low-intermediate risk factors. However, poor prognosis patients still exist and remain a challenge for investigations. Improving the use of chemotherapy and monoclonal antibodies will be the goals of the design of prospective studies.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Gisselbrecht, C. (2009). Treatment of aggressive lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), 1(8). https://doi.org/10.4081/hmr.v1i8.275
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).